<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30568575</article-id>
<article-id pub-id-type="pmc">6290346</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00448</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>UBE3A and Its Link With Autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vatsa</surname>
<given-names>Naman</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/619770/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jana</surname>
<given-names>Nihar Ranjan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/131956/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Cellular and Molecular Neuroscience Laboratory, National Brain Research Centre</institution>, <addr-line>Gurugram</addr-line>, <country>India</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Bioscience, Indian Institute of Technology</institution>, <addr-line>Kharagpur</addr-line>, <country>India</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ashok Hegde, Georgia College and State University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Eva Maria Jimenez-Mateos, Trinity College Dublin, Ireland; Amit Mishra, Indian Institute of Technology Jodhpur, India</p>
</fn>
<corresp id="c001">*Correspondence: Nihar Ranjan Jana <email>nihar@iitkgp.ac.in</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>448</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Vatsa and Jana.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Vatsa and Jana</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>UBE3A is a dual function protein consisting of ubiquitin ligase as well as transcriptional co-activator function. <italic>UBE3A</italic> gene is imprinted in the brain with preferential maternal-specific expression particularly in the neuron and loss of activity of the maternally inherited <italic>UBE3A</italic> causes Angelman syndrome (AS), characterized by severe mental retardation, lack of speech, seizures and autistic features. Interestingly, duplication, triplication, or gain-of-function mutations in the <italic>UBE3A</italic> gene are also linked with autism clinically distinguished by social impairments and stereotyped behaviors. These findings indicate that the expression and activity of UBE3A must be tightly regulated during brain development and UBE3A might be playing a crucial role in controlling synaptic function and plasticity through proteasome-mediated degradation as well as transcriptional regulation of its target proteins. In fact, several recent reports demonstrated the role of UBE3A in the modulation of synaptic function and plasticity. This review focuses on the critical role of UBE3A in regulating the synaptic function and how its altered activity is associated with autism.</p>
</abstract>
<kwd-group>
<kwd>UBE3A</kwd>
<kwd>autism</kwd>
<kwd>Angelman syndrome</kwd>
<kwd>synaptic plasticity</kwd>
<kwd>animal models</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Department of Biotechnology , Ministry of Science and Technology<named-content content-type="fundref-id">10.13039/501100001407</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="90"></ref-count>
<page-count count="8"></page-count>
<word-count count="6674"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>International classification of diseases (ICD-10) describes autism as an early onset neurodevelopmental disorder with three major characteristics feature: lack of communication, lack of social skills, and repetitive stereotyped behavior. With the extensive study in multiple new cases, the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) updated this definition in 2013, wherein, delayed language development was removed from the list of criteria and autism covered a host of diseases redefining itself as an autism spectrum disorder (ASD). First reports of autism were made by Leo Kanner and Hans Asperger in 1943–44. Both Kanner and Asperger defined a set of children withdrawn in their own world and failing to express themselves in social settings. Kanner termed this condition <italic>infantile autism</italic> while Asperger called it <italic>autistic psychopathy</italic>, both deriving their descriptions from schizophrenia and psychosis (Kanner, <xref ref-type="bibr" rid="B27">1968</xref>; Asperger, <xref ref-type="bibr" rid="B2">1991</xref>).</p>
<p>ASD has come a long way from its mid-twenties view of childhood psychosis to today, where it can be categorized according to its developmental pattern and co-morbidity with other diseases. ASD is a category of developmental disorders each with different behavioral phenotypes and severity and autism is the most common ASD. Improved diagnosis along with increased understanding of environmental risk factors has led to a considerable rise in the number of report worldwide. WHO report states that on an average 1 in 160 children's are suffering from ASD around the world, and it may occur more in males than in females. While the number of autistic cases continues to increase, the real cause behind the disease still remains a mystery. Reports suggest that environmental factors such as <italic>in utero</italic> exposure to alcohol, recreational drugs, pesticides, prenatal valproate exposure, nutritional deficiency, and maternal infections may hamper neural development leading to ASD (Roberts et al., <xref ref-type="bibr" rid="B64">2007</xref>; Christensen et al., <xref ref-type="bibr" rid="B6">2013</xref>; Volk et al., <xref ref-type="bibr" rid="B80">2013</xref>; Karimi et al., <xref ref-type="bibr" rid="B30">2017</xref>). A growing body of research also points at the complicated genetic etiology of ASD with almost 800 genes enlisted in the autism database (AUTdb). Synaptic scaffold (<italic>SHANK3</italic>) (Berkel et al., <xref ref-type="bibr" rid="B3">2010</xref>), calcium ion channel (<italic>CACNA1C</italic>) that are known to be associated with Timothy syndrome (de la Torre-Ubieta et al., <xref ref-type="bibr" rid="B10">2016</xref>) and GABA receptor genes (<italic>GABRB3, GABRA5, GABRG3</italic>) (Kim et al., <xref ref-type="bibr" rid="B34">2006</xref>; Klauck, <xref ref-type="bibr" rid="B36">2006</xref>; Vorstman et al., <xref ref-type="bibr" rid="B81">2006</xref>), genes encoding neuronal surface proteins (<italic>NLGN4X</italic>), intracellular trans-membrane proteins of the Golgi complex (<italic>POMGNT1</italic>), and genes responsible for proper cerebellar function (<italic>SYNE1</italic>) are important few names among multitude of genetic factors that may cause ASD (Vorstman et al., <xref ref-type="bibr" rid="B82">2017</xref>). Maternally inherited overexpression of <italic>UBE3A</italic> is currently thought to be the main cause underlying the Dup15q syndrome having typical autistic phenotypes (Cook et al., <xref ref-type="bibr" rid="B7">1997</xref>; Urraca et al., <xref ref-type="bibr" rid="B78">2013</xref>). Moreover, the loss of function of maternally inherited <italic>UBE3A</italic> is also associated with Angelman syndrome (AS), a neurodevelopmental disorder with severe mental retardation along with autistic features (Malzac et al., <xref ref-type="bibr" rid="B42">1998</xref>; Moncla et al., <xref ref-type="bibr" rid="B53">1999</xref>), thus making <italic>UBE3A</italic> a potential candidate gene to be studied for better understanding of autism. This review primarily focuses on the regulation of synaptic function and plasticity by UBE3A and how its abnormal function is associated with autism.</p>
</sec>
<sec id="s2">
<title>The 15q11-q13 Region: A Link Between <italic>UBE3A</italic> and Autism</title>
<p>The <italic>UBE3A</italic> gene is located on the proximal arm of the 15th chromosome at the q11–q13 site in humans, while it is found on the 7th chromosome in mouse (Kishino and Wagstaff, <xref ref-type="bibr" rid="B35">1998</xref>). Interestingly, majority of AS cases are due to the deletion of maternally derived copy of the 15q11–q13 chromosomal region. This region comprises many genes, one of which is <italic>UBE3A</italic> (Saitoh et al., <xref ref-type="bibr" rid="B65">1997</xref>). Furthermore, discovery of a various point mutations in the <italic>UBE3A</italic> gene in 5–10% cases of AS strongly implicated it as a causative factor for AS (Malzac et al., <xref ref-type="bibr" rid="B42">1998</xref>; Lossie et al., <xref ref-type="bibr" rid="B40">2001</xref>). AS is characterized by severe mental retardation, developmental delay, cognitive impairment, seizures, and excessive laughter a feature that led Dr. Harry Angelman name this disease the <italic>happy puppet syndrome</italic>. Other than being sociable, children with AS exhibit many features overlapping with autism. This has resulted in a debate among researchers, where some consider AS and ASD comorbid (Steffenburg et al., <xref ref-type="bibr" rid="B75">1996</xref>), while others believe AS to be distinct disorder (Williams et al., <xref ref-type="bibr" rid="B87">2001</xref>). Autism phenotypes also has been described to be associated with a number of other neuro-genetic disorders such as Rett syndrome, Tuberous sclerosis, and Fragile X syndrome (FXS) (Gillberg, <xref ref-type="bibr" rid="B14">1998</xref>). Recent studies have indicated that in about 20% cases of autism, a high number of small genomic DNA copy number variations (CNVs) were present (Sebat et al., <xref ref-type="bibr" rid="B70">2007</xref>; Morrow et al., <xref ref-type="bibr" rid="B54">2008</xref>; Weiss et al., <xref ref-type="bibr" rid="B86">2008</xref>; Glessner et al., <xref ref-type="bibr" rid="B15">2009</xref>). Interestingly, previous studies have also shown that maternally inherited 15q11–13 duplications and triplications are among the most common genomic CNVs identified in patients with autism (Cook et al., <xref ref-type="bibr" rid="B7">1997</xref>; Schroer et al., <xref ref-type="bibr" rid="B68">1998</xref>; Thomas et al., <xref ref-type="bibr" rid="B77">2003</xref>). Individuals having an inverted duplication of an extra maternal 15q11–13 segment (dup15), show mild autistic features, whereas individuals with two extra copies (triplication) resulting from an isodicentric extranumerary chromosome (idic15) display most of the autistic symptom whereas the paternal duplication of this region does not lead to autism (Hogart et al., <xref ref-type="bibr" rid="B21">2010</xref>). These studies suggest the involvement of imprinted genes lying within the duplicated chromosomal region as the cause of autism in these patients.</p>
<p>Interestingly, <italic>UBE3A</italic>, the AS gene, was identified as one of genes within the 15q11–q13 region which was solely expressed from the maternal allele in mature neurons (Albrecht et al., <xref ref-type="bibr" rid="B1">1997</xref>). Further, linkage disequilibrium at the 5′ end of <italic>UBE3A</italic> in families of autistic children (Nurmi et al., <xref ref-type="bibr" rid="B61">2001</xref>; Shao et al., <xref ref-type="bibr" rid="B71">2003</xref>) and paternally derived mutations at the same site not resulting in an autistic phenotype makes <italic>UBE3A</italic> a candidate gene for susceptibility to autism and related disorders. Earlier studies had suggested that <italic>ATP10A</italic>, a gene also lying at the 15q11–q13 site and expressed exclusively from the maternal chromosome (Meguro et al., <xref ref-type="bibr" rid="B46">2001</xref>; Kashiwagi et al., <xref ref-type="bibr" rid="B31">2003</xref>) could be another candidate gene for autism. However, this theory was later refuted, as <italic>ATP10A</italic> was not found to be maternally imprinted (Kayashima et al., <xref ref-type="bibr" rid="B32">2003</xref>; Nakatani et al., <xref ref-type="bibr" rid="B56">2009</xref>). Other genes coding for GABA<sub>A</sub> (γ-aminobutyric acid type A) receptor subunits β3, α5, γ3, and CYFIPI (cytoplasmic FMRP-interacting protein 1) are also reported in autism (Nishimura et al., <xref ref-type="bibr" rid="B58">2007</xref>; Hogart et al., <xref ref-type="bibr" rid="B21">2010</xref>), which suggests the involvement of genes other than <italic>UBE3A</italic> lying within the 15q11–q13 region in autistic pathophysiology.</p>
</sec>
<sec id="s3">
<title>UBE3A: The Jack of All Trades</title>
<p>The <italic>UBE3A</italic> gene encodes a 100 kDa protein that is functionally characterized as an E3 ubiquitin ligase belonging to the HECT (homologous to E6-AP C-terminus) domain family. As a part of the ubiquitin proteasome system, ubiquitin ligases (such as UBE3A) selectively target specific proteins for their ubiquitination and subsequent degradation by proteasome (Hershko and Ciechanover, <xref ref-type="bibr" rid="B20">1992</xref>). Interestingly, UBE3A was initially discovered in degrading tumor suppressor P53 protein by interacting with the viral E6 oncoprotein in cells infected with human papiloma virus (Scheffner et al., <xref ref-type="bibr" rid="B67">1993</xref>). Apart from its ligase activity, UBE3A also acts as a transcriptional co-activator (Nawaz et al., <xref ref-type="bibr" rid="B57">1999</xref>; Smith et al., <xref ref-type="bibr" rid="B73">2002</xref>; Khan et al., <xref ref-type="bibr" rid="B33">2006</xref>) and found to regulate cell cycle (Oda et al., <xref ref-type="bibr" rid="B62">1999</xref>; Mishra and Jana, <xref ref-type="bibr" rid="B52">2008</xref>; Mishra et al., <xref ref-type="bibr" rid="B50">2009a</xref>), synaptic function and plasticity (Reiter et al., <xref ref-type="bibr" rid="B63">2006</xref>; Greer et al., <xref ref-type="bibr" rid="B17">2010</xref>; Margolis et al., <xref ref-type="bibr" rid="B43">2010</xref>; Kaphzan et al., <xref ref-type="bibr" rid="B28">2011</xref>, <xref ref-type="bibr" rid="B29">2012</xref>; Mabb et al., <xref ref-type="bibr" rid="B41">2011</xref>; Sun et al., <xref ref-type="bibr" rid="B76">2015</xref>), and cellular protein quality control (Mishra et al., <xref ref-type="bibr" rid="B49">2008</xref>, <xref ref-type="bibr" rid="B51">2009b</xref>; Mulherkar et al., <xref ref-type="bibr" rid="B55">2009</xref>). Because of the link of UBE3A with AS and autism, researcher becomes increasingly interested to understand the regulation of synaptic function and plasticity by UBE3A. In fact, UBE3A has been shown to regulate synaptic plasticity and learning and memory formation by targeting activity regulated cytoskeleton-associated protein (Arc), a Rho guanine nucleotide exchange factor (Ephexin5), and small conductance calcium-activated potassium channel (SK2) (Greer et al., <xref ref-type="bibr" rid="B17">2010</xref>; Margolis et al., <xref ref-type="bibr" rid="B43">2010</xref>; Sun et al., <xref ref-type="bibr" rid="B76">2015</xref>). The expression of UBE3A is increased during experience-driven neuronal activity and increased UBE3A up-regulates excitatory synapse formation by regulating the level of Arc, a synaptic protein that induces internalization of AMPA types of glutamate receptor(Greer et al., <xref ref-type="bibr" rid="B17">2010</xref>). However, subsequent study failed to establish Arc as substrate of UBE3A and rather it is transcriptionally regulated by UBE3A (Kuhnle et al., <xref ref-type="bibr" rid="B38">2013</xref>). UBE3A also ubiquitinates SK2 and promotes its endocytosis resulting in increased NMDA receptor activation thus regulating synaptic plasticity (Sun et al., <xref ref-type="bibr" rid="B76">2015</xref>). The <italic>Ube3a</italic>-maternal deficient mice (AS model mice) generated by Jiang et al reproduced many characteristic features of AS including cognitive and motor deficits, audiogenic seizure, anxiety-like behavior, disturbances in circadian clock, and sleep homeostasis (Jiang et al., <xref ref-type="bibr" rid="B26">1998</xref>; Heck et al., <xref ref-type="bibr" rid="B19">2008</xref>; Godavarthi et al., <xref ref-type="bibr" rid="B16">2012</xref>; Shi et al., <xref ref-type="bibr" rid="B72">2015</xref>). These AS mice also shows defect in hippocampal calcium/calmodulin dependent protein kinase-II and long-term potentiation, experience-dependent synaptic plasticity, and imbalance of excitatory/inhibitory circuitry (Weeber et al., <xref ref-type="bibr" rid="B84">2003</xref>; Yashiro et al., <xref ref-type="bibr" rid="B89">2009</xref>; Sato and Stryker, <xref ref-type="bibr" rid="B66">2010</xref>; Wallace et al., <xref ref-type="bibr" rid="B83">2012</xref>). Many of these abnormalities in AS mice could be due to the altered level of SK2, Ephexin5, Arc, or some other novel substrates of UBE3A (shown in Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Role of UBE3A in regulating synaptic function and plasticity. Being an ubiquitin ligase, UBE3A could selectively target various synaptic proteins (Ephexin5, SK2 Arc etc.) through proteasome-mediated degradation and thereby regulates synaptic function and plasticity. UBE3A also could regulate the expression of various genes (Cbln1, Arc, HDAC1, and 2 etc.) linked with synaptic function by the virtue of its coactivator function. Loss of function or overactivation of UBE3A could potentially altered synaptic function and plasticity, the underlying cause of many behavioral deficits observed in both AS and autism. SH, steroid hormone; SHR, steroid hormone receptor; SHRE, steroid hormone response element; Ub, ubiquitin; E1, ubiquitin activating enzyme; E2, ubiquitin conjugating enzyme; E3, ubiquitin ligase.</p>
</caption>
<graphic xlink:href="fnmol-11-00448-g0001"></graphic>
</fig>
</sec>
<sec id="s4">
<title>Overdosage of UBE3A in Autism: Study on Animal Model</title>
<p>The first mouse model of autism was developed by Nakatani et al. (<xref ref-type="bibr" rid="B56">2009</xref>), where they used chromosomal engineering to duplicate a 6.3 Mb long mouse region orthologous to the human 15q11–13. This region encompassed many genes like <italic>Ndn, Ube3a, Atp10a, Gabrb3, Gabrb5, Gabrg3</italic>, and <italic>Herc2</italic>. Although this model showed behavioral abnormalities, they were mostly associated with paternally inherited duplication of the region. Since this result was not similar with maternal specific inheritance pattern of 15q11–13 duplications as observed in Dup15q syndrome patients (Cook et al., <xref ref-type="bibr" rid="B7">1997</xref>; Nakatani et al., <xref ref-type="bibr" rid="B56">2009</xref>; Urraca et al., <xref ref-type="bibr" rid="B78">2013</xref>; Ellegood et al., <xref ref-type="bibr" rid="B12">2015</xref>), this model did not truly represent the autistic phenotype. In order to delineate the role of over dosage of <italic>UBE3A</italic> in autism, Smith et al. generated a mouse model over expressing flagged tagged Ube3a by using bacterial artificial chromosome (BAC) recombinant technique. They inserted the 162 kb fragment of mouse chromosome 7 which contained the entire 78 kb coding sequence of <italic>Ube3a</italic> gene as well as its 63 kb 5′ and 21 kb 3′ extragenic sequence into FVB embryos, which were subsequently bred to produce single or double copy transgenic mice (Smith et al., <xref ref-type="bibr" rid="B74">2011</xref>). The flagged tagged <italic>Ube3a</italic> was expressed across all brain regions. In accordance with the idic15 autism phenotype, the mouse with three-fold increase in <italic>Ube3a</italic> (2xTg) had impaired social behavior and communication along with increase in repetitive behavior, which is the hallmark of autism. And similar to the dup15 phenotype, the mouse with two fold increase in brain <italic>Ube3a</italic> (1xTg) had a weaker autism penetrance with few of behavioral deficits. This model suggested that <italic>Ube3a</italic> is a dose sensitive gene and it is required in triplication to reconstitute the full set of symptoms of autism in a mouse model system.</p>
<p>Another mouse model of ASD carrying a point mutation in neuroligin 3 (<italic>NLGN3</italic>) showed increased GABAergic transmission, while mouse model for Rett syndrome (where neurons were depleted of <italic>MeCP2</italic>) showed decreased GABAergic transmission without affecting glutamatergic transmission (Chao et al., <xref ref-type="bibr" rid="B5">2010</xref>). In contrast, the Ube3a overexpression model showed reduction in glutamatergic synaptic transmission with minimal effect on GABAergic transmission in the neuron. There was no difference in the number of synapse and dendritic spine. However, presynaptic release probability and synaptic glutamate concentration was found to be significantly reduced in Ube3a overexpressing mice. This may have resulted in a reduction of mEPSCs, suggesting that excess Ube3a acts at multiple distinct sites within the pre-post synaptic compartment of neuronal circuitry and may impair excitatory synaptic transmission leaving the GABAergic synaptic transmission intact. Similar reports by Yashiro et al. (<xref ref-type="bibr" rid="B89">2009</xref>) showing reduced frequency of mEPSCs in visual cortex (layer 2/3) pyramidal neurons and reduction in glutamatergic transmission as shown by Greer et al. (<xref ref-type="bibr" rid="B17">2010</xref>) in AS mouse model, links both the loss and gain of function of Ube3a to abnormal neurodevelopment. These findings also elucidate the molecular and circuit mechanisms behind both types of mutations.</p>
<p>However, the link between increased Ube3a expression and the autistic phenotype still remained unclear. To clarify this association, Krishnan et al. (<xref ref-type="bibr" rid="B37">2017</xref>) identified 190 up-regulated and 408 down-regulated genes in <italic>Ube3a</italic> (2xTg) mice which were enriched for glutamatergic synaptic transmission. They found <italic>Cbln1</italic>, a gene which binds to Nrxn1/2/3 and postsynaptic GRID1/2 and is dose dependently affected by Ube3a. Both <italic>NRXN1/2/3</italic> and <italic>GRID1/2</italic> genes were found mutated in ASD in a network protein-protein interaction study (Matsuda et al., <xref ref-type="bibr" rid="B44">2010</xref>; Matsuda and Yuzaki, <xref ref-type="bibr" rid="B45">2011</xref>; Wei et al., <xref ref-type="bibr" rid="B85">2012</xref>; Elegheert et al., <xref ref-type="bibr" rid="B11">2016</xref>). They reported down regulation of <italic>Cbln1</italic> in both <italic>Ube3a</italic> (1xTg) and <italic>Ube3a</italic> (2xTg) mouse models. Krishnan et al. also observed social deficits similar to <italic>Ube3a</italic> (2xTg) mouse in animals with <italic>Cbln1</italic> deleted from VGLUT neurons specifically in the ventral tegmental area (VTA). They also reported that recurrent seizures reduced <italic>Cbln1</italic> expression along with impaired sociability. This result was supported by an earlier report that showed down-regulation of Cbln1 mRNA by increased neuronal activity after status epilepticus (Iijima et al., <xref ref-type="bibr" rid="B23">2009</xref>). This study suggested that Ube3a was needed for seizure induced decrease in sociability and the repression of <italic>Cbln1</italic>. Restoring <italic>CBLN1</italic> expression in VGLUT neurons of VTA rescued impaired sociability. Another study has shown increased level and activity of HDAC1/2 in AS mice brain (Jamal et al., <xref ref-type="bibr" rid="B25">2017</xref>). Since HDAC2 negatively regulates synaptic plasticity and memory formation (Guan et al., <xref ref-type="bibr" rid="B18">2009</xref>), its altered activity could lead to synaptic dysfunction in UBE3A-linked AS and autism. These findings indicate how transcriptional deregulation by Ube3a could be associated with abnormal synaptic function (see Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<p>In humans, <italic>UBE3A</italic> is expressed at eight alternatively spliced transcripts that encode for three protein isoforms (Yamamoto et al., <xref ref-type="bibr" rid="B88">1997</xref>; LaSalle et al., <xref ref-type="bibr" rid="B39">2015</xref>), whereas in mouse <italic>Ube3a</italic> expresses at least three alternatively spliced transcripts (Yamamoto et al., <xref ref-type="bibr" rid="B88">1997</xref>; Miao et al., <xref ref-type="bibr" rid="B48">2013</xref>). The function of each isoform of Ube3a in the brain is not clearly understood. Mio et al. suggest that isoform 2 of Ube3a is responsible for specification of apical dendrites and dendritic polarization of pyramidal neurons in the mouse cortex (Miao et al., <xref ref-type="bibr" rid="B48">2013</xref>). Ube3a isoform 1 has been reported to regulate dendritic spine development by sequestering miR-134—Limk1 complex, an enzyme involved in synaptogenesis (Valluy et al., <xref ref-type="bibr" rid="B79">2015</xref>). These studies suggest that each isoform of Ube3a is involved in some form of neuronal development, synaptogenesis and plasticity. Thus, mouse models were needed in order to study the effect of over expression of different isoforms with respect to autism. Copping et al. (<xref ref-type="bibr" rid="B8">2017</xref>), using the Tetracycline–Off (Tet-Off) expression system, developed and characterized a mouse model for autism, which over expressed Ube3a isoform 2 (analogous to human <italic>UBE3A</italic> isoform 3) in excitatory neurons. Ube3a isoform 2 plays a key role in neural development hence was the isoform of choice for this model. Behavioral abnormalities in this mouse model were robust in contrast to the <italic>Ube3a</italic> (2xTg) mouse developed by Smith et al. Although it showed normal growth in the first 2 weeks post birth and had normal motor and exploratory abilities, this model had fewer USV (Ultrasonic vocalization) at both early and later stages of development. Overexpression of Ube3a isoform 2 also led to anxiety and cognitive impairments. This mouse model exhibited a unique feature of reduced seizure threshold as well as volume reduction and dysmorphia of the hippocampus which was in accordance with the phenotype of Dup15 patients, where 60% patients have seizures and are known to have heteropias and dysplasias (Boronat et al., <xref ref-type="bibr" rid="B4">2015</xref>).</p>
</sec>
<sec id="s5">
<title>UBE3A and Autism: A Direct Link</title>
<p>Lossifov et al. conducted a whole genome sequencing study, where they found autism proband with a T485A missense mutation in <italic>UBE3A</italic> gene (Iossifov et al., <xref ref-type="bibr" rid="B24">2014</xref>). Yi et al. also reported this mutation and suggested that it may lead to abnormally elevated activity of UBE3A (Yi et al., <xref ref-type="bibr" rid="B90">2015</xref>). UBE3A maintains its optimum level via self-targeted degradation and is under tight control during normal brain development (Nuber et al., <xref ref-type="bibr" rid="B60">1998</xref>; de Bie and Ciechanover, <xref ref-type="bibr" rid="B9">2011</xref>; Mabb et al., <xref ref-type="bibr" rid="B41">2011</xref>). T485A missense mutation disrupts the protein kinase A (PKA) phosphorylation site which is known to inhibit UBE3A ligase activity toward itself and its substrates. This leads to increase in UBE3A activity. Interestingly, this mutation also results in increased number of dendritic spine formation thus provides a mechanistic insight about how increased expression or activity of UBE3A could lead to altered synaptic function and plasticity. Scoles et al. found elevated level of UBE3A transcript and protein in post mortem brains of Dup15q individuals (Scoles et al., <xref ref-type="bibr" rid="B69">2011</xref>). In accordance to this, Noor et al. have recently reported a family with 15q11.2 duplication limited to the <italic>UBE3A</italic> gene (Noor et al., <xref ref-type="bibr" rid="B59">2015</xref>). The Comparative Genomic Hybridisation (aCGH) analysis revealed 129 kb duplication at chromosome 15q11.2 which encompassed the entire <italic>UBE3A</italic> gene with an overlap of all the three isoforms of UBE3A. They did not find any other clinically significant CNV. This patient was born to a 32 year old mother, via Cesarean section. The baby was diagnosed with infantile osteopetrosis at 9th day after birth for which she underwent bone marrow transplantation (BMT) at the age of 4 months. She suffered global developmental delay, although she could later communicate with little vocabulary. She is social with friends at school and also can make good eye contact. Family history of the patient revealed learning disability, anxiety, and depression on the patient's maternal side. These reports strongly indicate that UBE3A is one of the major contributors to the autistic phenotype in cases with maternal interstitial 15q11–13 duplication.</p>
</sec>
<sec id="s6">
<title>Possible Therapies for Autism Targeting UBE3A: A Future Perspective</title>
<p>Realizing the potential of UBE3A in autism, Germain et al. in their iPSC lines from idic(15) patients restored normal UBE3A mRNA levels using antitumor antibiotic methamycin (Germain et al., <xref ref-type="bibr" rid="B13">2014</xref>). However, this approach requires extensive study as methamycin affects the expression of genes other than <italic>UBE3A</italic>. Yi et al. reported that chronic treatment with drugs targeting PKA, like forskolin and rolipram, can turn down UBE3A activity in neurons. This raises the possibility of targeting upstream regulators of UBE3A in order to rescue autistic symptoms (Yi et al., <xref ref-type="bibr" rid="B90">2015</xref>). Because the <italic>UBE3A</italic> is a paternally imprinted gene, its unsilencing could be a potential therapeutic strategy for AS and possibly other ASDs. Topoisomerase inhibitors have been found to unsilence the paternal <italic>Ube3a</italic> expression by inhibiting the expression of large noncoding antisense RNA transcript (UBE3A-ATS) (Huang et al., <xref ref-type="bibr" rid="B22">2011</xref>). However, topoisomerase inhibitors could alter the expression of number of other genes and therefore could have severe detrimental effect that requires extensive study. Recently, antisense oligonucleotide of UBE3A-ATS has been shown to activate the paternal <italic>Ube3a</italic> and improve the behavioral abnormalities in AS mice (Meng et al., <xref ref-type="bibr" rid="B47">2015</xref>). Similar strategy can also be tested to down-regulate Ube3a in rescuing autistic phenotypes in animals. Identification of novel substrates of UBE3A linked with synaptic function and plasticity could further lead to better understanding of the role of UBE3A in autism and AS that will eventually help in novel drug discovery. Detailed mechanistic study of neuronal circuit defects also need to be explored on models of ASD overexpressing UBE3A. Such studies will clearly elucidate the involvement of UBE3A in ASD and whether UBE3A alone could lead to such a robust autistic phenotype. Altogether, the finding of <italic>UBE3A</italic> as a candidate gene for autism is fairly new and holds promise in the future when mechanisms of action of UBE3A and its isoforms are elucidated, and upstream regulators of <italic>UBE3A</italic> gene are explored.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by Department of Biotechnology, Government of India to National Brain Research Centre and Ministry of Human Resource Development, Government of India to IIT-Kharagpur. NJ is a recipient of TATA Innovation Fellowship from Department of Biotechnology, Government of India (BT/HRD/35/01/03/2013).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>U.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Cattanach</surname><given-names>B. M.</given-names></name><name><surname>Beechey</surname><given-names>C. V.</given-names></name><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Eichele</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons</article-title>. <source/>Nat. Genet.
<volume>17</volume>, <fpage>75</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1038/ng0997-75</pub-id><pub-id pub-id-type="pmid">9288101</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Asperger</surname><given-names>H.</given-names></name></person-group> (<year>1991</year>). <article-title>Asperger and his syndrome,</article-title> in <source/>Autism and Asperger Syndrome, ed <person-group person-group-type="editor"><name><surname>Frith</surname><given-names>U.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>), <fpage>37</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1017/CBO9780511526770.001</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkel</surname><given-names>S.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Weiss</surname><given-names>B.</given-names></name><name><surname>Howe</surname><given-names>J.</given-names></name><name><surname>Roeth</surname><given-names>R.</given-names></name><name><surname>Moog</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation</article-title>. <source/>Nat. Genet.
<volume>42</volume>, <fpage>489</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1038/ng.589</pub-id><pub-id pub-id-type="pmid">20473310</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boronat</surname><given-names>S.</given-names></name><name><surname>Mehan</surname><given-names>W. A.</given-names></name><name><surname>Shaaya</surname><given-names>E. A.</given-names></name><name><surname>Thibert</surname><given-names>R. L.</given-names></name><name><surname>Caruso</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Hippocampal abnormalities in magnetic resonance imaging (MRI) of 15q duplication syndromes</article-title>. <source/>J. Child Neurol.
<volume>30</volume>, <fpage>333</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1177/0883073814538669</pub-id><pub-id pub-id-type="pmid">24985752</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>. <source/>Nature
<volume>468</volume>, <fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id><pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Gronborg</surname><given-names>T. K.</given-names></name><name><surname>Sorensen</surname><given-names>M. J.</given-names></name><name><surname>Schendel</surname><given-names>D.</given-names></name><name><surname>Parner</surname><given-names>E. T.</given-names></name><name><surname>Pedersen</surname><given-names>L. H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism</article-title>. <source/>JAMA
<volume>309</volume>, <fpage>1696</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2013.2270</pub-id><pub-id pub-id-type="pmid">23613074</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>E. H.</given-names><suffix>Jr</suffix></name><name><surname>Lindgren</surname><given-names>V.</given-names></name><name><surname>Leventhal</surname><given-names>B. L.</given-names></name><name><surname>Courchesne</surname><given-names>R.</given-names></name><name><surname>Lincoln</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Autism or atypical autism in maternally but not paternally derived proximal 15q duplication</article-title>. <source/>Am. J. Hum. Genet.
<volume>60</volume>, <fpage>928</fpage>–<lpage>934</lpage>.<pub-id pub-id-type="pmid">9106540</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copping</surname><given-names>N. A. S.</given-names></name><name><surname>Christian</surname><given-names>G. B.</given-names></name><name><surname>Ritter</surname><given-names>D. J.</given-names></name><name><surname>Islam</surname><given-names>M. S.</given-names></name><name><surname>Buscher</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>26</volume>, <fpage>3995</fpage>–<lpage>4010</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx289</pub-id><pub-id pub-id-type="pmid">29016856</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bie</surname><given-names>P.</given-names></name><name><surname>Ciechanover</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms</article-title>. <source/>Cell Death Differ.
<volume>18</volume>, <fpage>1393</fpage>–<lpage>1402</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2011.16</pub-id><pub-id pub-id-type="pmid">21372847</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre-Ubieta</surname><given-names>L.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>J. L.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title>. <source/>Nat. Med.
<volume>22</volume>, <fpage>345</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4071</pub-id><pub-id pub-id-type="pmid">27050589</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elegheert</surname><given-names>J.</given-names></name><name><surname>Kakegawa</surname><given-names>W.</given-names></name><name><surname>Clay</surname><given-names>J. E.</given-names></name><name><surname>Shanks</surname><given-names>N. F.</given-names></name><name><surname>Behiels</surname><given-names>E.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Structural basis for integration of GluD receptors within synaptic organizer complexes</article-title>. <source/>Science
<volume>353</volume>, <fpage>295</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1126/science.aae0104</pub-id><pub-id pub-id-type="pmid">27418511</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellegood</surname><given-names>J.</given-names></name><name><surname>Nakai</surname><given-names>N.</given-names></name><name><surname>Nakatani</surname><given-names>J.</given-names></name><name><surname>Henkelman</surname><given-names>M.</given-names></name><name><surname>Takumi</surname><given-names>T.</given-names></name><name><surname>Lerch</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroanatomical phenotypes are consistent with autism-like behavioral phenotypes in the 15q11-13 duplication mouse model</article-title>. <source/>Autism Res.
<volume>8</volume>, <fpage>545</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1469</pub-id><pub-id pub-id-type="pmid">25755142</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>N. D.</given-names></name><name><surname>Chen</surname><given-names>P. F.</given-names></name><name><surname>Plocik</surname><given-names>A. M.</given-names></name><name><surname>Glatt-Deeley</surname><given-names>H.</given-names></name><name><surname>Brown</surname><given-names>J.</given-names></name><name><surname>Fink</surname><given-names>J. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1</article-title>. <source/>Mol. Autism
<volume>5</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-5-44</pub-id><pub-id pub-id-type="pmid">25694803</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillberg</surname><given-names>C.</given-names></name></person-group> (<year>1998</year>). <article-title>Chromosomal disorders and autism</article-title>. <source/>J. Autism Dev. Disord.
<volume>28</volume>, <fpage>415</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1023/A:1026004505764</pub-id><pub-id pub-id-type="pmid">9813777</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Cai</surname><given-names>G.</given-names></name><name><surname>Korvatska</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>C. E.</given-names></name><name><surname>Wood</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes</article-title>. <source/>Nature
<volume>459</volume>, <fpage>569</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1038/nature07953</pub-id><pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godavarthi</surname><given-names>S. K.</given-names></name><name><surname>Dey</surname><given-names>P.</given-names></name><name><surname>Maheshwari</surname><given-names>M.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>21</volume>, <fpage>1824</fpage>–<lpage>1834</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr614</pub-id><pub-id pub-id-type="pmid">22215440</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>P. L.</given-names></name><name><surname>Hanayama</surname><given-names>R.</given-names></name><name><surname>Bloodgood</surname><given-names>B. L.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Lipton</surname><given-names>D. M.</given-names></name><name><surname>Flavell</surname><given-names>S. W.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc</article-title>. <source/>Cell
<volume>140</volume>, <fpage>704</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.026</pub-id><pub-id pub-id-type="pmid">20211139</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>J. S.</given-names></name><name><surname>Haggarty</surname><given-names>S. J.</given-names></name><name><surname>Giacometti</surname><given-names>E.</given-names></name><name><surname>Dannenberg</surname><given-names>J. H.</given-names></name><name><surname>Joseph</surname><given-names>N.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>HDAC2 negatively regulates memory formation and synaptic plasticity</article-title>. <source/>Nature
<volume>459</volume>, <fpage>55</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/nature07925</pub-id><pub-id pub-id-type="pmid">19424149</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heck</surname><given-names>D. H.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>LeDoux</surname><given-names>M. S.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors</article-title>. <source/>Hum. Mol. Genet.
<volume>17</volume>, <fpage>2181</fpage>–<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn117</pub-id><pub-id pub-id-type="pmid">18413322</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershko</surname><given-names>A.</given-names></name><name><surname>Ciechanover</surname><given-names>A.</given-names></name></person-group> (<year>1992</year>). <article-title>The ubiquitin system for protein degradation</article-title>. <source/>Annu. Rev. Biochem.
<volume>61</volume>, <fpage>761</fpage>–<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.bi.61.070192.003553</pub-id><pub-id pub-id-type="pmid">1323239</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogart</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>LaSalle</surname><given-names>J. M.</given-names></name><name><surname>Schanen</surname><given-names>N. C.</given-names></name></person-group> (<year>2010</year>). <article-title>The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13</article-title>. <source/>Neurobiol. Dis.
<volume>38</volume>, <fpage>181</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.08.011</pub-id><pub-id pub-id-type="pmid">18840528</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H. S.</given-names></name><name><surname>Allen</surname><given-names>J. A.</given-names></name><name><surname>Mabb</surname><given-names>A. M.</given-names></name><name><surname>King</surname><given-names>I. F.</given-names></name><name><surname>Miriyala</surname><given-names>J.</given-names></name><name><surname>Taylor-Blake</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons</article-title>. <source/>Nature
<volume>481</volume>, <fpage>185</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1038/nature10726</pub-id><pub-id pub-id-type="pmid">22190039</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>T.</given-names></name><name><surname>Emi</surname><given-names>K.</given-names></name><name><surname>Yuzaki</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Activity-dependent repression of Cbln1 expression: mechanism for developmental and homeostatic regulation of synapses in the cerebellum</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>5425</fpage>–<lpage>5434</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4473-08.2009</pub-id><pub-id pub-id-type="pmid">19403810</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>. <source/>Nature
<volume>515</volume>, <fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamal</surname><given-names>I.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Vatsa</surname><given-names>N.</given-names></name><name><surname>Shekhar</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>B. K.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome</article-title>. <source/>Neurobiol. Dis.
<volume>105</volume>, <fpage>99</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2017.05.010</pub-id><pub-id pub-id-type="pmid">28576709</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>U.</given-names></name><name><surname>Atkins</surname><given-names>C. M.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Eichele</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation</article-title>. <source/>Neuron
<volume>21</volume>, <fpage>799</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80596-6</pub-id><pub-id pub-id-type="pmid">9808466</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanner</surname><given-names>L.</given-names></name></person-group> (<year>1968</year>). <article-title>Autistic disturbances of affective contact</article-title>. <source/>Acta Paedopsychiatr.
<volume>35</volume>, <fpage>100</fpage>–<lpage>136</lpage>.<pub-id pub-id-type="pmid">4880460</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaphzan</surname><given-names>H.</given-names></name><name><surname>Buffington</surname><given-names>S. A.</given-names></name><name><surname>Jung</surname><given-names>J. I.</given-names></name><name><surname>Rasband</surname><given-names>M. N.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>17637</fpage>–<lpage>17648</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4162-11.2011</pub-id><pub-id pub-id-type="pmid">22131424</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaphzan</surname><given-names>H.</given-names></name><name><surname>Hernandez</surname><given-names>P.</given-names></name><name><surname>Jung</surname><given-names>J. I.</given-names></name><name><surname>Cowansage</surname><given-names>K. K.</given-names></name><name><surname>Deinhardt</surname><given-names>K.</given-names></name><name><surname>Chao</surname><given-names>M. V.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors</article-title>. <source/>Biol. Psychiatry
<volume>72</volume>, <fpage>182</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.01.021</pub-id><pub-id pub-id-type="pmid">22381732</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>P.</given-names></name><name><surname>Kamali</surname><given-names>E.</given-names></name><name><surname>Mousavi</surname><given-names>S. M.</given-names></name><name><surname>Karahmadi</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Environmental factors influencing the risk of autism</article-title>. <source/>J. Res. Med. Sci.
<volume>22</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.4103/1735-1995.200272</pub-id><pub-id pub-id-type="pmid">28413424</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwagi</surname><given-names>A.</given-names></name><name><surname>Meguro</surname><given-names>M.</given-names></name><name><surname>Hoshiya</surname><given-names>H.</given-names></name><name><surname>Haruta</surname><given-names>M.</given-names></name><name><surname>Ishino</surname><given-names>F.</given-names></name><name><surname>Shibahara</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb</article-title>. <source/>J. Hum. Genet.
<volume>48</volume>, <fpage>194</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1007/s10038-003-0009-3</pub-id><pub-id pub-id-type="pmid">12730723</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayashima</surname><given-names>T.</given-names></name><name><surname>Yamasaki</surname><given-names>K.</given-names></name><name><surname>Joh</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Ohta</surname><given-names>T.</given-names></name><name><surname>Yoshiura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Atp10a, the mouse ortholog of the human imprinted ATP10A gene, escapes genomic imprinting</article-title>. <source/>Genomics
<volume>81</volume>, <fpage>644</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/S0888-7543(03)00077-6</pub-id><pub-id pub-id-type="pmid">12782135</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>O. Y.</given-names></name><name><surname>Fu</surname><given-names>G.</given-names></name><name><surname>Ismail</surname><given-names>A.</given-names></name><name><surname>Srinivasan</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name><name><surname>Tu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland</article-title>. <source/>Mol. Endocrinol.
<volume>20</volume>, <fpage>544</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1210/me.2005-0110</pub-id><pub-id pub-id-type="pmid">16254014</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. A.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Cho</surname><given-names>I. H.</given-names></name><name><surname>Yoo</surname><given-names>H. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios</article-title>. <source/>Neuropsychobiology
<volume>54</volume>, <fpage>160</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1159/000098651</pub-id><pub-id pub-id-type="pmid">17230033</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishino</surname><given-names>T.</given-names></name><name><surname>Wagstaff</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Genomic organization of the UBE3A/E6-AP gene and related pseudogenes</article-title>. <source/>Genomics
<volume>47</volume>, <fpage>101</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1997.5093</pub-id><pub-id pub-id-type="pmid">9465301</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klauck</surname><given-names>S. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Genetics of autism spectrum disorder</article-title>. <source/>Eur. J. Hum. Genet.
<volume>14</volume>, <fpage>714</fpage>–<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201610</pub-id><pub-id pub-id-type="pmid">16721407</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V.</given-names></name><name><surname>Stoppel</surname><given-names>D. C.</given-names></name><name><surname>Nong</surname><given-names>Y.</given-names></name><name><surname>Johnson</surname><given-names>M. A.</given-names></name><name><surname>Nadler</surname><given-names>M. J.</given-names></name><name><surname>Ozkaynak</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1</article-title>. <source/>Nature
<volume>543</volume>, <fpage>507</fpage>–<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1038/nature21678</pub-id><pub-id pub-id-type="pmid">28297715</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhnle</surname><given-names>S.</given-names></name><name><surname>Mothes</surname><given-names>B.</given-names></name><name><surname>Matentzoglu</surname><given-names>K.</given-names></name><name><surname>Scheffner</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>110</volume>, <fpage>8888</fpage>–<lpage>8893</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1302792110</pub-id><pub-id pub-id-type="pmid">23671107</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaSalle</surname><given-names>J. M.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Chamberlain</surname><given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders</article-title>. <source/>Epigenomics
<volume>7</volume>, <fpage>1213</fpage>–<lpage>1228</lpage>. <pub-id pub-id-type="doi">10.2217/epi.15.70</pub-id><pub-id pub-id-type="pmid">26585570</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lossie</surname><given-names>A. C.</given-names></name><name><surname>Whitney</surname><given-names>M. M.</given-names></name><name><surname>Amidon</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>H. J.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Theriaque</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Distinct phenotypes distinguish the molecular classes of Angelman syndrome</article-title>. <source/>J. Med. Genet.
<volume>38</volume>, <fpage>834</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.12.834</pub-id><pub-id pub-id-type="pmid">11748306</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabb</surname><given-names>A. M.</given-names></name><name><surname>Judson</surname><given-names>M. C.</given-names></name><name><surname>Zylka</surname><given-names>M. J.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes</article-title>. <source/>Trends Neurosci.
<volume>34</volume>, <fpage>293</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2011.04.001</pub-id><pub-id pub-id-type="pmid">21592595</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malzac</surname><given-names>P.</given-names></name><name><surname>Webber</surname><given-names>H.</given-names></name><name><surname>Moncla</surname><given-names>A.</given-names></name><name><surname>Graham</surname><given-names>J. M.</given-names></name><name><surname>Kukolich</surname><given-names>M.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Mutation analysis of UBE3A in Angelman syndrome patients</article-title>. <source/>Am. J. Hum. Genet.
<volume>62</volume>, <fpage>1353</fpage>–<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1086/301877</pub-id><pub-id pub-id-type="pmid">9585605</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>S. S.</given-names></name><name><surname>Salogiannis</surname><given-names>J.</given-names></name><name><surname>Lipton</surname><given-names>D. M.</given-names></name><name><surname>Mandel-Brehm</surname><given-names>C.</given-names></name><name><surname>Wills</surname><given-names>Z. P.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation</article-title>. <source/>Cell
<volume>143</volume>, <fpage>442</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.09.038</pub-id><pub-id pub-id-type="pmid">21029865</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Miura</surname><given-names>E.</given-names></name><name><surname>Miyazaki</surname><given-names>T.</given-names></name><name><surname>Kakegawa</surname><given-names>W.</given-names></name><name><surname>Emi</surname><given-names>K.</given-names></name><name><surname>Narumi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer</article-title>. <source/>Science
<volume>328</volume>, <fpage>363</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1126/science.1185152</pub-id><pub-id pub-id-type="pmid">20395510</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Yuzaki</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Cbln family proteins promote synapse formation by regulating distinct neurexin signaling pathways in various brain regions</article-title>. <source/>Eur. J. Neurosci.
<volume>33</volume>, <fpage>1447</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07638.x</pub-id><pub-id pub-id-type="pmid">21410790</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meguro</surname><given-names>M.</given-names></name><name><surname>Kashiwagi</surname><given-names>A.</given-names></name><name><surname>Mitsuya</surname><given-names>K.</given-names></name><name><surname>Nakao</surname><given-names>M.</given-names></name><name><surname>Kondo</surname><given-names>I.</given-names></name><name><surname>Saitoh</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome</article-title>. <source/>Nat. Genet.
<volume>28</volume>, <fpage>19</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/ng0501-19</pub-id><pub-id pub-id-type="pmid">11326269</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>L.</given-names></name><name><surname>Ward</surname><given-names>A. J.</given-names></name><name><surname>Chun</surname><given-names>S.</given-names></name><name><surname>Bennett</surname><given-names>C. F.</given-names></name><name><surname>Beaudet</surname><given-names>A. L.</given-names></name><name><surname>Rigo</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Towards a therapy for Angelman syndrome by targeting a long non-coding RNA</article-title>. <source/>Nature
<volume>518</volume>, <fpage>409</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1038/nature13975</pub-id><pub-id pub-id-type="pmid">25470045</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>G. H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>327</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2509-12.2013</pub-id><pub-id pub-id-type="pmid">23283345</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Dikshit</surname><given-names>P.</given-names></name><name><surname>Purkayastha</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>J.</given-names></name><name><surname>Nukina</surname><given-names>N.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2008</year>). <article-title>E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>7648</fpage>–<lpage>7656</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M706620200</pub-id><pub-id pub-id-type="pmid">18201976</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Godavarthi</surname><given-names>S. K.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2009a</year>). <article-title>UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27</article-title>. <source/>Neurobiol. Dis.
<volume>36</volume>, <fpage>26</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.06.010</pub-id><pub-id pub-id-type="pmid">19591933</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Godavarthi</surname><given-names>S. K.</given-names></name><name><surname>Maheshwari</surname><given-names>M.</given-names></name><name><surname>Goswami</surname><given-names>A.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2009b</year>). <article-title>The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins</article-title>. <source/>J. Biol. Chem.
<volume>284</volume>, <fpage>10537</fpage>–<lpage>10545</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M806804200</pub-id><pub-id pub-id-type="pmid">19233847</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome</article-title>. <source/>Cell. Mol. Life Sci.
<volume>65</volume>, <fpage>656</fpage>–<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-007-7476-1</pub-id><pub-id pub-id-type="pmid">18193166</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncla</surname><given-names>A.</given-names></name><name><surname>Malzac</surname><given-names>P.</given-names></name><name><surname>Livet</surname><given-names>M. O.</given-names></name><name><surname>Voelckel</surname><given-names>M. A.</given-names></name><name><surname>Mancini</surname><given-names>J.</given-names></name><name><surname>Delaroziere</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling</article-title>. <source/>J. Med. Genet.
<volume>36</volume>, <fpage>554</fpage>–<lpage>560</lpage>.<pub-id pub-id-type="pmid">10424818</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>E. M.</given-names></name><name><surname>Yoo</surname><given-names>S. Y.</given-names></name><name><surname>Flavell</surname><given-names>S. W.</given-names></name><name><surname>Kim</surname><given-names>T. K.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Hill</surname><given-names>R. S.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Identifying autism loci and genes by tracing recent shared ancestry</article-title>. <source/>Science
<volume>321</volume>, <fpage>218</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1126/science.1157657</pub-id><pub-id pub-id-type="pmid">18621663</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulherkar</surname><given-names>S. A.</given-names></name><name><surname>Sharma</surname><given-names>J.</given-names></name><name><surname>Jana</surname><given-names>N. R.</given-names></name></person-group> (<year>2009</year>). <article-title>The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein</article-title>. <source/>J. Neurochem.
<volume>110</volume>, <fpage>1955</fpage>–<lpage>1964</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06293.x</pub-id><pub-id pub-id-type="pmid">19645749</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>J.</given-names></name><name><surname>Tamada</surname><given-names>K.</given-names></name><name><surname>Hatanaka</surname><given-names>F.</given-names></name><name><surname>Ise</surname><given-names>S.</given-names></name><name><surname>Ohta</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism</article-title>. <source/>Cell
<volume>137</volume>, <fpage>1235</fpage>–<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.04.024</pub-id><pub-id pub-id-type="pmid">19563756</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nawaz</surname><given-names>Z.</given-names></name><name><surname>Lonard</surname><given-names>D. M.</given-names></name><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>Lev-Lehman</surname><given-names>E.</given-names></name><name><surname>Tsai</surname><given-names>S. Y.</given-names></name><name><surname>Tsai</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily</article-title>. <source/>Mol. Cell. Biol.
<volume>19</volume>, <fpage>1182</fpage>–<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.19.2.1182</pub-id><pub-id pub-id-type="pmid">9891052</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>C. L.</given-names></name><name><surname>Vazquez-Lopez</surname><given-names>A.</given-names></name><name><surname>Spence</surname><given-names>S. J.</given-names></name><name><surname>Alvarez-Retuerto</surname><given-names>A. I.</given-names></name><name><surname>Sigman</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways</article-title>. <source/>Hum. Mol. Genet.
<volume>16</volume>, <fpage>1682</fpage>–<lpage>1698</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm116</pub-id><pub-id pub-id-type="pmid">17519220</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Dupuis</surname><given-names>L.</given-names></name><name><surname>Mittal</surname><given-names>K.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>15q11.2 duplication encompassing only the UBE3A gene is associated with developmental delay and neuropsychiatric phenotypes</article-title>. <source/>Hum. Mutat.
<volume>36</volume>, <fpage>689</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22800</pub-id><pub-id pub-id-type="pmid">25884337</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuber</surname><given-names>U.</given-names></name><name><surname>Schwarz</surname><given-names>S. E.</given-names></name><name><surname>Scheffner</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate</article-title>. <source/>Eur. J. Biochem.
<volume>254</volume>, <fpage>643</fpage>–<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.1998.2540643.x</pub-id><pub-id pub-id-type="pmid">9688277</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurmi</surname><given-names>E. L.</given-names></name><name><surname>Bradford</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><name><surname>Arnone</surname><given-names>B.</given-names></name><name><surname>Gardiner</surname><given-names>M. B.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families</article-title>. <source/>Genomics
<volume>77</volume>, <fpage>105</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1006/geno.2001.6617</pub-id><pub-id pub-id-type="pmid">11543639</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>H.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Howley</surname><given-names>P. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>96</volume>, <fpage>9557</fpage>–<lpage>9562</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.17.9557</pub-id><pub-id pub-id-type="pmid">10449731</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Seagroves</surname><given-names>T. N.</given-names></name><name><surname>Bowers</surname><given-names>M.</given-names></name><name><surname>Bier</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase</article-title>. <source/>Hum. Mol. Genet.
<volume>15</volume>, <fpage>2825</fpage>–<lpage>2835</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl225</pub-id><pub-id pub-id-type="pmid">16905559</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>E. M.</given-names></name><name><surname>English</surname><given-names>P. B.</given-names></name><name><surname>Grether</surname><given-names>J. K.</given-names></name><name><surname>Windham</surname><given-names>G. C.</given-names></name><name><surname>Somberg</surname><given-names>L.</given-names></name><name><surname>Wolff</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley</article-title>. <source/>Environ. Health Perspect.
<volume>115</volume>, <fpage>1482</fpage>–<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.10168</pub-id><pub-id pub-id-type="pmid">17938740</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>S.</given-names></name><name><surname>Buiting</surname><given-names>K.</given-names></name><name><surname>Cassidy</surname><given-names>S. B.</given-names></name><name><surname>Conroy</surname><given-names>J. M.</given-names></name><name><surname>Driscoll</surname><given-names>D. J.</given-names></name><name><surname>Gabriel</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation</article-title>. <source/>Am. J. Med. Genet.
<volume>68</volume>, <fpage>195</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19970120)68:2&lt;195::AID-AJMG15&gt;3.0.CO;2-P</pub-id><pub-id pub-id-type="pmid">9028458</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Stryker</surname><given-names>M. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>107</volume>, <fpage>5611</fpage>–<lpage>5616</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1001281107</pub-id><pub-id pub-id-type="pmid">20212164</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheffner</surname><given-names>M.</given-names></name><name><surname>Huibregtse</surname><given-names>J. M.</given-names></name><name><surname>Vierstra</surname><given-names>R. D.</given-names></name><name><surname>Howley</surname><given-names>P. M.</given-names></name></person-group> (<year>1993</year>). <article-title>The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53</article-title>. <source/>Cell
<volume>75</volume>, <fpage>495</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90384-3</pub-id><pub-id pub-id-type="pmid">8221889</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroer</surname><given-names>R. J.</given-names></name><name><surname>Phelan</surname><given-names>M. C.</given-names></name><name><surname>Michaelis</surname><given-names>R. C.</given-names></name><name><surname>Crawford</surname><given-names>E. C.</given-names></name><name><surname>Skinner</surname><given-names>S. A.</given-names></name><name><surname>Cuccaro</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Autism and maternally derived aberrations of chromosome 15q</article-title>. <source/>Am. J. Med. Genet.
<volume>76</volume>, <fpage>327</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19980401)76:4&lt;327::AID-AJMG8&gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">9545097</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scoles</surname><given-names>H. A.</given-names></name><name><surname>Urraca</surname><given-names>N.</given-names></name><name><surname>Chadwick</surname><given-names>S. W.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Lasalle</surname><given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples</article-title>. <source/>Mol. Autism
<volume>2</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-2-19</pub-id><pub-id pub-id-type="pmid">22152151</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J.</given-names></name><name><surname>Lakshmi</surname><given-names>B.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Troge</surname><given-names>J.</given-names></name><name><surname>Lese-Martin</surname><given-names>C.</given-names></name><name><surname>Walsh</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Strong association of de novo copy number mutations with autism</article-title>. <source/>Science
<volume>316</volume>, <fpage>445</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1126/science.1138659</pub-id><pub-id pub-id-type="pmid">17363630</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Cuccaro</surname><given-names>M. L.</given-names></name><name><surname>Hauser</surname><given-names>E. R.</given-names></name><name><surname>Raiford</surname><given-names>K. L.</given-names></name><name><surname>Menold</surname><given-names>M. M.</given-names></name><name><surname>Wolpert</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes</article-title>. <source/>Am. J. Hum. Genet.
<volume>72</volume>, <fpage>539</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1086/367846</pub-id><pub-id pub-id-type="pmid">12567325</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S. Q.</given-names></name><name><surname>Bichell</surname><given-names>T. J.</given-names></name><name><surname>Ihrie</surname><given-names>R. A.</given-names></name><name><surname>Johnson</surname><given-names>C. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Ube3a imprinting impairs circadian robustness in Angelman syndrome models</article-title>. <source/>Curr. Biol.
<volume>25</volume>, <fpage>537</fpage>–<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2014.12.047</pub-id><pub-id pub-id-type="pmid">25660546</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>DeVera</surname><given-names>D. G.</given-names></name><name><surname>Lamb</surname><given-names>D. J.</given-names></name><name><surname>Nawaz</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Beaudet</surname><given-names>A. L.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction</article-title>. <source/>Mol. Cell. Biol.
<volume>22</volume>, <fpage>525</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.22.2.525-535.2002</pub-id><pub-id pub-id-type="pmid">11756548</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. E.</given-names></name><name><surname>Zhou</surname><given-names>Y. D.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Stoppel</surname><given-names>D. C.</given-names></name><name><surname>Anderson</surname><given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice</article-title>. <source/>Sci. Transl. Med.
<volume>3</volume>:<fpage>103r</fpage>a97. <pub-id pub-id-type="doi">10.1126/scitranslmed.3002627</pub-id><pub-id pub-id-type="pmid">21974935</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffenburg</surname><given-names>S.</given-names></name><name><surname>Gillberg</surname><given-names>C. L.</given-names></name><name><surname>Steffenburg</surname><given-names>U.</given-names></name><name><surname>Kyllerman</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Autism in Angelman syndrome: a population-based study</article-title>. <source/>Pediatr. Neurol.
<volume>14</volume>, <fpage>131</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/0887-8994(96)00011-2</pub-id><pub-id pub-id-type="pmid">8703225</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Standley</surname><given-names>S.</given-names></name><name><surname>Ji</surname><given-names>A.</given-names></name><name><surname>Tunuguntla</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis</article-title>. <source/>Cell Rep.
<volume>12</volume>, <fpage>449</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.023</pub-id><pub-id pub-id-type="pmid">26166566</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>J. A.</given-names></name><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Peterson Kraai</surname><given-names>T. L.</given-names></name><name><surname>Wilson</surname><given-names>R.</given-names></name><name><surname>Tartaglia</surname><given-names>N.</given-names></name><name><surname>LeRoux</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Genetic and clinical characterization of patients with an interstitial duplication 15q11-q13, emphasizing behavioral phenotype and response to treatment</article-title>. <source/>Am. J. Med. Genet. A
<volume>119A</volume>, <fpage>111</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.10176</pub-id><pub-id pub-id-type="pmid">12749048</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urraca</surname><given-names>N.</given-names></name><name><surname>Cleary</surname><given-names>J.</given-names></name><name><surname>Brewer</surname><given-names>V.</given-names></name><name><surname>Pivnick</surname><given-names>E. K.</given-names></name><name><surname>McVicar</surname><given-names>K.</given-names></name><name><surname>Thibert</surname><given-names>R. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature</article-title>. <source/>Autism Res.
<volume>6</volume>, <fpage>268</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1284</pub-id><pub-id pub-id-type="pmid">23495136</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valluy</surname><given-names>J.</given-names></name><name><surname>Bicker</surname><given-names>S.</given-names></name><name><surname>Aksoy-Aksel</surname><given-names>A.</given-names></name><name><surname>Lackinger</surname><given-names>M.</given-names></name><name><surname>Sumer</surname><given-names>S.</given-names></name><name><surname>Fiore</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A coding-independent function of an alternative Ube3a transcript during neuronal development</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>666</fpage>–<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3996</pub-id><pub-id pub-id-type="pmid">25867122</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>H. E.</given-names></name><name><surname>Lurmann</surname><given-names>F.</given-names></name><name><surname>Penfold</surname><given-names>B.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><name><surname>McConnell</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Traffic-related air pollution, particulate matter, and autism</article-title>. <source/>JAMA Psychiatry
<volume>70</volume>, <fpage>71</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.266</pub-id><pub-id pub-id-type="pmid">23404082</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorstman</surname><given-names>J. A.</given-names></name><name><surname>Staal</surname><given-names>W. G.</given-names></name><name><surname>van Daalen</surname><given-names>E.</given-names></name><name><surname>van Engeland</surname><given-names>H.</given-names></name><name><surname>Hochstenbach</surname><given-names>P. F.</given-names></name><name><surname>Franke</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism</article-title>. <source/>Mol. Psychiatry
<volume>11</volume>, <fpage>18</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001757</pub-id><pub-id pub-id-type="pmid">16205736</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorstman</surname><given-names>J. A. S.</given-names></name><name><surname>Parr</surname><given-names>J. R.</given-names></name><name><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><name><surname>Anney</surname><given-names>R. J. L.</given-names></name><name><surname>Nurnberger</surname><given-names>J. I.</given-names></name><name><surname>Jr</surname><given-names>Hallmayer, J. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Autism genetics: opportunities and challenges for clinical translation</article-title>. <source/>Nat. Rev. Genet.
<volume>18</volume>, <fpage>362</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2017.4</pub-id><pub-id pub-id-type="pmid">28260791</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>M. L.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Weinberg</surname><given-names>R. J.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>793</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.036</pub-id><pub-id pub-id-type="pmid">22681684</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeber</surname><given-names>E. J.</given-names></name><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Elgersma</surname><given-names>Y.</given-names></name><name><surname>Varga</surname><given-names>A. W.</given-names></name><name><surname>Carrasquillo</surname><given-names>Y.</given-names></name><name><surname>Brown</surname><given-names>S. E.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>2634</fpage>–<lpage>2644</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-07-02634.2003</pub-id><pub-id pub-id-type="pmid">12684449</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Pattarini</surname><given-names>R.</given-names></name><name><surname>Rong</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Bansal</surname><given-names>P. K.</given-names></name><name><surname>Kusnoor</surname><given-names>S. V.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The Cbln family of proteins interact with multiple signaling pathways</article-title>. <source/>J. Neurochem.
<volume>121</volume>, <fpage>717</fpage>–<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07648.x</pub-id><pub-id pub-id-type="pmid">22220752</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L. A.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Korn</surname><given-names>J. M.</given-names></name><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Fossdal</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Association between microdeletion and microduplication at 16p11.2 and autism</article-title>. <source/>N. Engl. J. Med.
<volume>358</volume>, <fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id><pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C. A.</given-names></name><name><surname>Lossie</surname><given-names>A.</given-names></name><name><surname>Driscoll</surname><given-names>D.</given-names></name><name><surname>Unit</surname><given-names>R. C. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Angelman syndrome: mimicking conditions and phenotypes</article-title>. <source/>Am. J. Med. Genet.
<volume>101</volume>, <fpage>59</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1316</pub-id><pub-id pub-id-type="pmid">11343340</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Huibregtse</surname><given-names>J. M.</given-names></name><name><surname>Howley</surname><given-names>P. M.</given-names></name></person-group> (<year>1997</year>). <article-title>The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing</article-title>. <source/>Genomics
<volume>41</volume>, <fpage>263</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1997.4617</pub-id><pub-id pub-id-type="pmid">9143503</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>K.</given-names></name><name><surname>Riday</surname><given-names>T. T.</given-names></name><name><surname>Condon</surname><given-names>K. H.</given-names></name><name><surname>Roberts</surname><given-names>A. C.</given-names></name><name><surname>Bernardo</surname><given-names>D. R.</given-names></name><name><surname>Prakash</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Ube3a is required for experience-dependent maturation of the neocortex</article-title>. <source/>Nat. Neurosci.
<volume>12</volume>, <fpage>777</fpage>–<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2327</pub-id><pub-id pub-id-type="pmid">19430469</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>J. J.</given-names></name><name><surname>Berrios</surname><given-names>J.</given-names></name><name><surname>Newbern</surname><given-names>J. M.</given-names></name><name><surname>Snider</surname><given-names>W. D.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name><name><surname>Hahn</surname><given-names>K. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A</article-title>. <source/>Cell
<volume>162</volume>, <fpage>795</fpage>–<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.06.045</pub-id><pub-id pub-id-type="pmid">26255772</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>